share_log
Breakings ·  Jun 27 21:34
Recursion Pharmaceuticals Shares Drop 20% After Co Files for Deep-Discounted $200 Million Stock Offering
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment